BN IMMUNOTHERAPEUTICS
BN ImmunoTherapeutics is a company that was acquired by Bavarian Nordic in 2009.
Similar Organizations
ImagePoint
ImagePoint is a company that was acquired by LinguaSol in 2010.
Visual Numerics
Visual Numerics is a company that was acquired by Rogue Wave Software in 2009.
More informations about "BN ImmunoTherapeutics"
BN ImmunoTherapeutics - PitchBook
BN ImmunoTherapeutics General Information Description. Developer and manufacturer of cancer vaccines. The company provides research services with focus on cancer vaccine.See details»
Bavarian Nordic
Mar 31, 2025 Bavarian Nordic - a pioneering force in vaccines – expanding our reach and impact through life-changing solutionsSee details»
BN-ImmunoTherapeutics - LinkedIn
BN-ImmunoTherapeutics | 152 followers on LinkedIn. Cancer VaccinesSee details»
Bavarian Nordic acquires BN ImmunoTherapeutics - Crunchbase
BN ImmunoTherapeutics BN ImmunoTherapeutics is a company that was acquired by Bavarian Nordic in 2009. Acquiring Organization: Bavarian Nordic Bavarian Nordic is a industrial …See details»
BN ImmunoTherapeutics - Drug pipelines, Patents, Clinical trials
Explore BN ImmunoTherapeutics with its drug pipeline, therapeutic area, technology platform, 3 literature.See details»
BN IMMUNOTHERAPEUTICS, INC. :: California (US) - OpenCorporates
Feb 19, 2010 Free and open company data on California (US) company BN IMMUNOTHERAPEUTICS, INC. (company number 2754612), 2425 GARCIA AVE …See details»
BN ImmunoTherapeutics Inc - Company Profile and News
Company profile page for BN ImmunoTherapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
BN IMMUNOTHERAPEUTICS, INC. Employer Identification Number …
Information about BN IMMUNOTHERAPEUTICS, INC.'s IRS EIN. Employer Identification Number 20-2561827 BN IMMUNOTHERAPEUTICS, INC. is a USA domiciled entity or foreign entity …See details»
Research programme: cancer vaccines - Bavarian Nordic/National …
Bavarian Nordic and the National Cancer Institute (NCI) are jointly developing immunotherapies for the treatment of multiple cancers. The immunotherapiesSee details»
BN ImmunoTherapeutics Announces Partnership With National
Aug 13, 2008 Reiner Laus, MD, President & CEO of BN ImmunoTherapeutics said: “The NCI relationship opens up for us new and exciting opportunities within the field of cancer and we …See details»
BN ImmunoTherapeutics - Tech Stack, Apps, Patents
BN ImmunoTherapeutics is a company that was acquired by Bavarian Nordic in 2009. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. ... Experience the new …See details»
CV 301 - AdisInsight - Springer
CV 301 is a CEA-MUC-1-TRICOM cancer vaccine for the treatment of various cancers being developed by BN ImmunoTherapeutics (a subsidiary of Bavarian Nordic) and CV 301 ... If your …See details»
BN ImmunoTherapeutics Starts Clinical Trials with Prostate Cancer …
Jul 9, 2008 BN ImmunoTherapeutics, Inc. (Mountain View, CA), has initiated Phase 1/2 clinical studies with its therapeutic vaccine candidate against prostate cancer. News All News Top …See details»
MVA-BN-PRO - AdisInsight
BN Immunotherapeutics, a subsidiary of Bavarian Nordic, was developing a vaccine for the treatment of prostate cancer. The vaccine, MVA-BN-PRO, is designed to ... If your …See details»
MVA-BN-PRO (Bavarian Nordic) - Drug Targets, Indications, …
MVA-BN-PRO (BN ImmunoTherapeutics) is a candidate immunotherapy product for the treatment of prostate cancer. It encodes 2 tumor-associated antigens, prostate-specific antigen (PSA), …See details»
BN ImmunoTherapeutics - Crunchbase
BN ImmunoTherapeutics is a company that was acquired by Bavarian Nordic in 2009.See details»
202562024 EIN ( TAX ID ) | BN IMMUNOTHERAPEUTICS, INC.
BN IMMUNOTHERAPEUTICS, INC. Conformed submission company name, business name, organization name, etc. 650-681-4660. Business address telephone number. 2425 GARCIA …See details»
Abstract A21: Active immunotherapy with PROSTVAC
Apr 2, 2014 Abstract. BN ImmunoTherapeutics (BNIT) specializes in developing novel active immunotherapies for cancer. These therapies use recombinant poxviruses engineered to …See details»
BN ImmunoTherapeutics - Contacts, Employees, Board Members …
BN ImmunoTherapeutics is a company that was acquired by Bavarian Nordic in 2009. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
Clinical trials of broadly neutralizing monoclonal antibodies in …
Apr 6, 2025 Introduction HIV-1 remains a major global health challenge, impacting approximately 39 million people worldwide. Although antiretroviral therapy has substantially …See details»